Tomas Kiselak
Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Tomas Kiselak
Tomas Kiselak is recorded as Chairman at Viridian Therapeutics, Inc.\DE (VRDN). Viridian Therapeutics, Inc.\DE reported in an 8-K filed June 16, 2023 that Tomas Kiselak was appointed Class II director, effective June 14, 2023.
“At the Annual Meeting, each of the Company's director nominees was elected and the other proposals voted on were approved.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
Start not stated–present
-
Start not stated–2021-04-30
Last confirmed by a filing; no departure on record
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Viridian Therapeutics, Inc.\DE
Other people whose current roles at this company are on record from its filings.
- Lee Rauch CEO, COO, Board Member
- Scott Myers CEO, Board Member
- Stephen Mahoney CEO, Board Member
- Seth Harmon CFO
- Jonathan Violin COO
- Thomas Beetham COO
- Lara Meisner General Counsel
- Kristian Humer Chief Accounting Officer
- Arlene M. Morris Board Member
- Chris Cain Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.